Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev. 2006; 19 (2):CD003287.Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with ...
Insulin infusion therapy in critical care patients: Regular insulin vs short- acting insulin. A prospective, crossover, randomized, multicenter blind study ☆ , ☆☆ Federico Bilotta, MD, PhD a, ⁎, Rafael Badenes, MD b , Simona Lolli, MD a , Francisco Javier Belda, MD b , Sharon Ein...
Aim: Short-acting insulin analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial glucose, while their superiority on haemoglobin A1c (HbA1c) is controversial. Method: All randomized controlled trials (RCTs) with a duration >4 weeks comparing short-acti...
Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus The aim of the present study was to compare the usefulness of premeal rapid-acting and regular insulin in type 2 diabetes patients. A total of 56...
Any other medicine known as a short-acting insulin Any of the ingredients in the specific product dispensed Your pharmacist can tell you all of the ingredients in the specific insulin regular products they stock. Low Blood Sugar (Hypoglycemia). Insulin regular should not be used if you are havi...
A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire:... We examined quality-of-life (QOL) of patients with a prospective comparison of multiple daily insulin injections therapy (16 patients in MD...
My beloved nerdy husband and partner, Rob, did a short analysis back in 2008 when we requested to be removed. He found an approximate attrition rate of 33% of the then 733 total Compact signers. A random sampling of those companies removed found 65% of them still in business, indicating ...
Insulin infusion therapy in critical care patients: regular insulin vs short-acting insulin. A prospective, crossover, randomized, multicenter blind study. J Crit Care 2015;30:437.e1-6.Bilotta F, Badenes R, Lolli S, et al. Insulin infusion therapy in critical care patients: regular insulin...
Bilotta F, Badenes R, Lolli S, et al. Insulin infusion therapy in critical care patients: regular insulin vs short-acting insulin. A prospective, crossover, randomized, multicenter blind study. J Crit Care 2015;30:437.e1-6.Federico Bilotta, Rafael Badenes, Simona Lolli, Francisco Javier ...
Despite this theoretical superiority of short acting insulin analogues over regular human insulin, the risk-benefit ratio of short acting insulin analogues in the treatment of diabetic patients is still unclear. Objectives To assess the effect of treatment with short acting insulin analogues versus ...